Loading company…
Riskpilot
← Back to search
Sign in
Get full access
7H Medical AB
AB
Active
Org 5594106642
Prästliden 3
Wholesale of perfume and cosmetics · NACE 4645
Est. 2022
1-4 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2024
SEK 2,3M
+216% vs 2023
EBITDA margin
19.0%
+649% vs 2023
Equity ratio
30.7%
Financial strength
Net profit 2024
SEK 245K
+678% vs 2023
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
Key figures
Annual report 2024
Revenue
SEK 2,3M
+216%
EBITDA
SEK 442K
+649%
Net profit
SEK 245K
+678%
Total assets
SEK 982K
+132%
Equity
SEK 301K
+433%
Employees
—
—
Company information
Legal name
7H Medical AB
Org number
5594106642
Legal form
Aktiebolag
NACE code
4645 · Wholesale of perfume and cosmetics
Founded
8 december 2022
Share capital
SEK 25 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna suppleanten
Company purpose
Företaget skall importera klinikutrustning samt behandlingsmaterial för medicinska behandlingar och skönhetsvård.
Contact
Address
Prästliden 3
Email
economy@hastmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of perfume and cosmetics
Companies in Mark
All Sweden companies
Revenue
SEK millions
0M
1M
1M
2M
2M
1M
2023
2M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
734
2 320
Staff expenses
—
—
EBITDA
59
442
Depreciation & amort.
—
—
EBIT
59
442
Net financials
−0
−1
Profit before tax
42
321
Tax
−11
−76
Net profit
31
245
Balance sheet
SEK thousands
Item
2023
2024
Total assets
423
982
Equity
56
301
Long-term debt
—
—
Short-term debt
349
544
Total debt
349
544
Financial ratios
5-year trend
EBITDA margin
19.0%
This company
15.8%
Market median
+20% vs market
2023
2024
Equity ratio
30.7%
This company
38.2%
Market median
+20% vs market
2023
2024
Return on equity
81.3%
This company
18.4%
Market median
+342% vs market
2023
2024
Net profit margin
10.5%
This company
8.1%
Market median
+30% vs market
2023
2024
Asset turnover
2.36×
This company
1.12×
Market median
+111% vs market
2023
2024
Debt / equity
2.26×
This company
0.62×
Market median
-265% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-12-08 – 2023-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
SV
Sa-Ngiam Victoria Hast
Chief Executive Officer
Chief Executive Officer
2025
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
TS
Tan Sa-Ngiam Hast
Chairman
2022
BH
Bo Henrik Ingemar Hast
Deputy Board Member
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of 7H Medical AB also hold positions in
0
other companies.
Person
Role here
Other companies
Sa-Ngiam Victoria Hast
Chief Executive Officer
0 companies
Tan Sa-Ngiam Hast
Chairman
0 companies
Bo Henrik Ingemar Hast
Deputy Board Member
0 companies